US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.700
  • +0.080+4.94%
Close Dec 27 16:00 ET
  • 1.679
  • -0.021-1.24%
Post 16:48 ET
69.84MMarket Cap-5.67P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.82%2.17M
-29.49%8.31M
-46.26%1.34M
-41.89%1.66M
-27.61%2.76M
-2.62%2.54M
72.50%11.78M
7.26%2.49M
52.37%2.86M
255.99%3.81M
Selling and administrative expenses
-13.84%1.1M
-23.02%4.76M
-18.99%872.66K
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
126.43%1.94M
-General and administrative expense
-13.84%1.1M
-23.02%4.76M
-18.99%872.66K
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
126.43%1.94M
Research and development costs
3.51%1.31M
-36.63%3.55M
-67.00%467.71K
-31.30%748.34K
-43.17%1.06M
3.80%1.27M
89.10%5.6M
26.74%1.42M
19.01%1.09M
778.16%1.87M
Other operating expenses
---245.36K
----
----
----
----
----
----
----
----
----
Operating profit
14.82%-2.17M
29.49%-8.31M
46.26%-1.34M
41.89%-1.66M
27.61%-2.76M
2.62%-2.54M
-72.50%-11.78M
-7.26%-2.49M
-52.37%-2.86M
-255.99%-3.81M
Net non-operating interest income expense
-161.04%-33.69K
5.83%97.79K
-158,066.67%-9.48K
-89.40%8.39K
395.51%43.68K
55.2K
1,160.32%92.41K
6
79.15K
8.82K
Non-operating interest income
-52.89%26.01K
169.48%249.02K
836,866.67%50.22K
-13.98%68.08K
756.65%75.52K
--55.2K
1,160.32%92.41K
--6
--79.15K
--8.82K
Non-operating interest expense
--59.7K
--151.23K
--59.7K
--59.7K
--31.84K
--0
--0
--0
--0
--0
Other net income (expense)
-103.70%-283
122.51%9.26K
89.64%-124
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
-1,111.66%-22.65K
Other non- operating income (expenses)
-103.70%-283
122.51%9.26K
89.64%-124
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
-1,111.66%-22.65K
Income before tax
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Income tax
Net income
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Net income continuous Operations
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Minority interest income
Net income attributable to the parent company
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Basic earnings per share
20.00%-0.08
31.91%-0.32
50.00%-0.05
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
-200.00%-0.15
Diluted earnings per share
20.00%-0.08
31.91%-0.32
50.00%-0.05
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
-200.00%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -14.82%2.17M-29.49%8.31M-46.26%1.34M-41.89%1.66M-27.61%2.76M-2.62%2.54M72.50%11.78M7.26%2.49M52.37%2.86M255.99%3.81M
Selling and administrative expenses -13.84%1.1M-23.02%4.76M-18.99%872.66K-48.39%915.91K-12.63%1.7M-8.27%1.27M59.79%6.18M-10.78%1.08M84.04%1.77M126.43%1.94M
-General and administrative expense -13.84%1.1M-23.02%4.76M-18.99%872.66K-48.39%915.91K-12.63%1.7M-8.27%1.27M59.79%6.18M-10.78%1.08M84.04%1.77M126.43%1.94M
Research and development costs 3.51%1.31M-36.63%3.55M-67.00%467.71K-31.30%748.34K-43.17%1.06M3.80%1.27M89.10%5.6M26.74%1.42M19.01%1.09M778.16%1.87M
Other operating expenses ---245.36K------------------------------------
Operating profit 14.82%-2.17M29.49%-8.31M46.26%-1.34M41.89%-1.66M27.61%-2.76M2.62%-2.54M-72.50%-11.78M-7.26%-2.49M-52.37%-2.86M-255.99%-3.81M
Net non-operating interest income expense -161.04%-33.69K5.83%97.79K-158,066.67%-9.48K-89.40%8.39K395.51%43.68K55.2K1,160.32%92.41K679.15K8.82K
Non-operating interest income -52.89%26.01K169.48%249.02K836,866.67%50.22K-13.98%68.08K756.65%75.52K--55.2K1,160.32%92.41K--6--79.15K--8.82K
Non-operating interest expense --59.7K--151.23K--59.7K--59.7K--31.84K--0--0--0--0--0
Other net income (expense) -103.70%-283122.51%9.26K89.64%-124117.74%2.32K97.38%-5943,511.79%7.66K-2,215.48%-41.15K73.92%-1.2K-514.91%-13.08K-1,111.66%-22.65K
Other non- operating income (expenses) -103.70%-283122.51%9.26K89.64%-124117.74%2.32K97.38%-5943,511.79%7.66K-2,215.48%-41.15K73.92%-1.2K-514.91%-13.08K-1,111.66%-22.65K
Income before tax 11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M
Income tax
Net income 11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M
Net income continuous Operations 11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M
Minority interest income
Net income attributable to the parent company 11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M
Basic earnings per share 20.00%-0.0831.91%-0.3250.00%-0.0545.45%-0.0626.67%-0.119.09%-0.1-62.07%-0.470.00%-0.1-37.50%-0.11-200.00%-0.15
Diluted earnings per share 20.00%-0.0831.91%-0.3250.00%-0.0545.45%-0.0626.67%-0.119.09%-0.1-62.07%-0.470.00%-0.1-37.50%-0.11-200.00%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List